Mark Your Calendar for Next Year's Hybrid Event!
September 27-30, 2022,
Boston Convention and Exhibition Center
THE LARGEST BIOPROCESSING EVENT FOR LEARNING HOW TO ACCELERATE PROMISING BIOLOGICS, CELL & GENE THERAPIES TOWARDS COMMERCIAL SUCCESS
Get the latest event updates
Learn from the brightest minds in bioprocessing
Each year, BPI's scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production. Below are some of the key speakers who are presented at BPI 2021.
Access Novel Science Across the Entire Bioprocessing Spectrum
Our BPI 2021 agenda includes 9 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies. Your registration provides access to the presentations across all 9 tracks, allowing you to create an agenda tailored specifically for your needs.
Manufacturing Strategy & Bioprocessing 4.0
Apply digital technologies, artificial intelligence and machine learning to increase manufacturing efficiency through smart and data-driven bioprocessing.
Cell Culture & Upstream Processing
Optimize speed, titers, efficiency and quality in upstream process development.
Recovery & Purification
Apply novel technologies that are enabling next generation downstream processes to overcome bottlenecks and optimize manufacturing, quality and control of emerging modalities.
Analytical & Quality
Achieve a high quality product using optimal analytical strategies while reducing timelines.
Intensified & Continuous Processing
Accelerate manufacturing timelines by achieving intensified and fully continuous processing from the development, optimization and implementation of novel technologies, analytical tools and automated systems.
Speed from Gene to Market
Gain the industry insights you need to accelerate speed and compress timelines to IND and BLA submissions.
Build your analytical toolbox to improve testing, characterization & validation strategies
Gene Edited Ex Vivo Cell Therapy
Overcome autologous and allogeneic manufacturing challenges with novel modalities, gene editing and more
In Vivo Gene Therapy
Learn about next generation cells lines, production optimization & novel platforms
Lars Pampel, Ph.D., Head, Process Sciences, Technical Development, New Biological Entities, Novartis, Switzerland
“BPI brings leading thoughts and discussion to a balanced audience of scientists and decision makers.”
CONNECT WITH KEY BUYERS BY BECOMING A BPI SPONSOR/EXHIBITOR
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals in today's virtual environment.
(Companies A-L) Contact Jennifer Wickett: Jennifer.Wickett@informa.com | +1-857-504-6694
(Companies M-Z) Contact Blake Shuka: Blake.Shuka@informa.com | +1-857-504-6684